R&D Quality

R&D Quality Assurance covering GxP compliance for nonclinical (GLP) and clinical (GCP) development activities — distinct from GMP manufacturing/commercial QA. Centers on auditing (investigator sites, CROs, laboratories, Phase 1 units, IMP/service providers), vendor/sponsor oversight of outsourced studies, quality-system processes (deviation/CAPA, document control), inspection readiness, and serving as regulatory liaison for FDA/USDA/OECD compliance. Excludes GMP product-release QA, QC laboratory testing, and validation engineering as standalone disciplines.

12 leveled profiles. Pick a level to see the full profile.

Individual contributor

P1R&D Quality Assurance — P1

R&D Quality Assurance covering GxP compliance for nonclinical (GLP) and clinical (GCP) development activities — distinct from GMP manufacturing/commercial QA. Centers on auditing (investigator sites, CROs, laboratories, Phase 1 units, IMP/service providers), vendor/sponsor oversight of outsourced studies, quality-system processes (deviation/CAPA, document control), inspection readiness, and serving as regulatory liaison for FDA/USDA/OECD compliance. Excludes GMP product-release QA, QC laboratory testing, and validation engineering as standalone disciplines.

P1R&D Quality Control — P1

Performs analytical and microbiological testing of raw materials, in-process, finished, environmental, and stability samples to verify product quality and support release decisions. Distinct from R&D Quality Assurance (systems/audit focus) and Regulatory Affairs (submissions), this focus centers on hands-on bench testing (HPLC/UPLC/CE/LC-MS/MS), method validation per ICH Q2(R1), stability programs, and deviation/CAPA investigations within GMP/GLP labs.

P2R&D Quality Assurance — P2

R&D Quality Assurance covering GxP compliance for nonclinical (GLP) and clinical (GCP) development activities — distinct from GMP manufacturing/commercial QA. Centers on auditing (investigator sites, CROs, laboratories, Phase 1 units, IMP/service providers), vendor/sponsor oversight of outsourced studies, quality-system processes (deviation/CAPA, document control), inspection readiness, and serving as regulatory liaison for FDA/USDA/OECD compliance. Excludes GMP product-release QA, QC laboratory testing, and validation engineering as standalone disciplines.

P2R&D Quality Control — P2

Performs analytical and microbiological testing of raw materials, in-process, finished, environmental, and stability samples to verify product quality and support release decisions. Distinct from R&D Quality Assurance (systems/audit focus) and Regulatory Affairs (submissions), this focus centers on hands-on bench testing (HPLC/UPLC/CE/LC-MS/MS), method validation per ICH Q2(R1), stability programs, and deviation/CAPA investigations within GMP/GLP labs.

P3R&D Quality Assurance — P3

R&D Quality Assurance covering GxP compliance for nonclinical (GLP) and clinical (GCP) development activities — distinct from GMP manufacturing/commercial QA. Centers on auditing (investigator sites, CROs, laboratories, Phase 1 units, IMP/service providers), vendor/sponsor oversight of outsourced studies, quality-system processes (deviation/CAPA, document control), inspection readiness, and serving as regulatory liaison for FDA/USDA/OECD compliance. Excludes GMP product-release QA, QC laboratory testing, and validation engineering as standalone disciplines.

P3R&D Quality Control — P3

Performs analytical and microbiological testing of raw materials, in-process, finished, environmental, and stability samples to verify product quality and support release decisions. Distinct from R&D Quality Assurance (systems/audit focus) and Regulatory Affairs (submissions), this focus centers on hands-on bench testing (HPLC/UPLC/CE/LC-MS/MS), method validation per ICH Q2(R1), stability programs, and deviation/CAPA investigations within GMP/GLP labs.

P4R&D Quality Assurance — P4

R&D Quality Assurance covering GxP compliance for nonclinical (GLP) and clinical (GCP) development activities — distinct from GMP manufacturing/commercial QA. Centers on auditing (investigator sites, CROs, laboratories, Phase 1 units, IMP/service providers), vendor/sponsor oversight of outsourced studies, quality-system processes (deviation/CAPA, document control), inspection readiness, and serving as regulatory liaison for FDA/USDA/OECD compliance. Excludes GMP product-release QA, QC laboratory testing, and validation engineering as standalone disciplines.

P4R&D Quality Control — P4

Performs analytical and microbiological testing of raw materials, in-process, finished, environmental, and stability samples to verify product quality and support release decisions. Distinct from R&D Quality Assurance (systems/audit focus) and Regulatory Affairs (submissions), this focus centers on hands-on bench testing (HPLC/UPLC/CE/LC-MS/MS), method validation per ICH Q2(R1), stability programs, and deviation/CAPA investigations within GMP/GLP labs.

P5R&D Quality Assurance — P5

R&D Quality Assurance covering GxP compliance for nonclinical (GLP) and clinical (GCP) development activities — distinct from GMP manufacturing/commercial QA. Centers on auditing (investigator sites, CROs, laboratories, Phase 1 units, IMP/service providers), vendor/sponsor oversight of outsourced studies, quality-system processes (deviation/CAPA, document control), inspection readiness, and serving as regulatory liaison for FDA/USDA/OECD compliance. Excludes GMP product-release QA, QC laboratory testing, and validation engineering as standalone disciplines.

P5R&D Quality Control — P5

Performs analytical and microbiological testing of raw materials, in-process, finished, environmental, and stability samples to verify product quality and support release decisions. Distinct from R&D Quality Assurance (systems/audit focus) and Regulatory Affairs (submissions), this focus centers on hands-on bench testing (HPLC/UPLC/CE/LC-MS/MS), method validation per ICH Q2(R1), stability programs, and deviation/CAPA investigations within GMP/GLP labs.

P6R&D Quality Control — P6

Performs analytical and microbiological testing of raw materials, in-process, finished, environmental, and stability samples to verify product quality and support release decisions. Distinct from R&D Quality Assurance (systems/audit focus) and Regulatory Affairs (submissions), this focus centers on hands-on bench testing (HPLC/UPLC/CE/LC-MS/MS), method validation per ICH Q2(R1), stability programs, and deviation/CAPA investigations within GMP/GLP labs.

P6R&D Quality Assurance — P6

R&D Quality Assurance covering GxP compliance for nonclinical (GLP) and clinical (GCP) development activities — distinct from GMP manufacturing/commercial QA. Centers on auditing (investigator sites, CROs, laboratories, Phase 1 units, IMP/service providers), vendor/sponsor oversight of outsourced studies, quality-system processes (deviation/CAPA, document control), inspection readiness, and serving as regulatory liaison for FDA/USDA/OECD compliance. Excludes GMP product-release QA, QC laboratory testing, and validation engineering as standalone disciplines.